Altmed can explain when these options may be reasonable and when a safer alternative should come first
More than half of the participants lost even more weight than that, and 77% lost at least 5% of their starting body weight
Safety Considerations: Tirzepatide is not recommended for those with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, a history of pancreatitis, or severe gastrointestinal disease
For active adults, former athletes, busy parents, and patients across Princeton, Lawrenceville, West Windsor, Plainsboro, Hopewell, Pennington, Robbinsville, and Mercer County NJ, this is an important mindset shift
Clinical research on Epithalon and Epithalamin spans over 15 published trials